Functional integration of acute myeloid leukemia into the vascular niche

Leukemia

Volumn 28, Issue 10, 2014, Pages 1978-1987

  Cogle, C R ^a   Goldman, D C ^b   Madlambayan, G J ^a,c   Leon, R P ^b   Al Masri, A ^b   Clark, H A ^b   Asbaghi, S A ^b   Tyner, J W ^b   Dunlap, J ^b   Fan, G ^b   Kovacsovics, T ^b   Liu, Q ^b   Meacham, A ^a   Hamlin, K L ^b   Hromas, R A ^a   Scott, E W ^a   Fleming, W H ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; MESSENGER RNA; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL FUSION; CELL INTERACTION; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIC INFILTRATION; LIVER BIOPSY; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR TISSUE; YOUNG ADULT; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; CELL LINE; CELL SURVIVAL; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOPHYSIOLOGY; RECURRENT DISEASE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; MALE; MICE; MICE, INBRED NOD; MIDDLE AGED; NEOPLASM TRANSPLANTATION; PHENOTYPE; RECEPTORS, CELL SURFACE; RECURRENCE; YOUNG ADULT;

EID: 84921733102     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.109     Document Type: Article

References (52)

1. Burnett A, Wetzler M, Lowenberg B. Therapeutic advances in acute myeloid leukemia. J Clin Oncol 2011; 29: 487-494
2. Buccisano F, Maurillo L, Del Principe MI, Del Poeta G, Sconocchia G, Lo-Coco F et al. Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. Blood 2012; 119: 332-341
3. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309-322
4. Lathia JD, Heddleston JM, Venere M, Rich JN. Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell 2011; 8: 482-485
5. Dvorak HF, Weaver VM, Tlsty TD, Bergers G. Tumor microenvironment and progression. J Surg Oncol 2011; 103: 468-474
6. Bailey AS, Fleming WH. Converging roads: evidence for an adult hemangioblast. Exp Hematol 2003; 31: 987-993
7. Cogle CR, Scott EW. The hemangioblast: cradle to clinic. Exp Hematol 2004; 32: 885-890
8. Grant MB, May WS, Caballero S, Brown GA, Guthrie SM, Mames RN et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002; 8: 607-612
9. Cogle CR, Wainman DA, Jorgensen ML, Guthrie SM, Mames RN, Scott EW. Adult human hematopoietic cells provide functional hemangioblast activity. Blood 2004; 103: 133-135
10. Bailey AS, Jiang S, Afentoulis M, Baumann CI, Schroeder DA, Olson SB et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 2004; 103: 13-19
11. Bailey AS, Willenbring H, Jiang S, Anderson DA, Schroeder DA, Wong MH et al. Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci USA 2006; 103: 13156-13161
12. Madlambayan GJ, Butler JM, Hosaka K, Jorgensen M, Fu D, Guthrie SM et al. Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger. Blood 2009; 114: 4310-4319
13. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121: 1109-1121
14. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006; 25: 977-988
15. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834
16. Butler JM, Nolan DJ, Vertes EL, Varnum-Finney B, Kobayashi H, Hooper AT et al. Endothelial cells are essential for the self-renewal and repopulation of Notchdependent hematopoietic stem cells. Cell Stem Cell 2010; 6: 251-264
17. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012; 481: 457-462
18. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309-313
19. Ribatti D. Is angiogenesis essential for the progression of hematological malignancies or is it an epiphenomenon? Leukemia 2009; 23: 433-434
20. Fragioudaki M, Tsirakis G, Pappa CA, Aristeidou I, Tsioutis C, Alegakis A et al. Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma. Leuk Res 2012; 36: 1004-1008
21. Korkolopoulou P, Thymara I, Kavantzas N, Vassilakopoulos TP, Angelopoulou MK, Kokoris SI et al. Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications. Leukemia 2005; 19: 894-900
22. Lundberg LG, Hellstrom-Lindberg E, Kanter-Lewensohn L, Lerner R, Palmblad J. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes. Leuk Res 2006; 30: 247-253
23. Rajkumar SV, Greipp PR. Angiogenesis in multiple myeloma. Br J Haematol 2001; 113: 565
24. Hatfield K, Oyan AM, Ersvaer E, Kalland KH, Lassalle P, Gjertsen BT et al. Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators. Br J Haematol 2009; 144: 53-68
25. Hatfield K, Ryningen A, Corbascio M, Bruserud O. Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts. Int J Cancer 2006; 119: 2313-2321
26. Hatfield KJ, Evensen L, Reikvam H, Lorens JB, Bruserud O. Soluble mediators released by acute myeloid leukemia cells increase capillary-like networks. Eur J Haematol 2012; 89: 478-490
27. Liesveld JL, Rosell KE, Lu C, Bechelli J, Phillips G, Lancet JE et al. Acute myelogenous leukemia-microenvironment interactions: role of endothelial cells and proteasome inhibition. Hematology 2005; 10: 483-494
28. Trujillo A, McGee C, Cogle CR. Angiogenesis in acute myeloid leukemia and opportunities for novel therapies. J Oncol 2012; 2012: 128608
29. Critser PJ, Yoder MC. Endothelial colony-forming cell role in neoangiogenesis and tissue repair. Curr Opin Organ Transplant 2010; 15: 68-72
30. Hooper AT, Butler JM, Nolan DJ, Kranz A, Iida K, Kobayashi M et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 2009; 4: 263-274
31. Overturf K, Al-Dhalimy M, Tanguay R, Brantly M, Ou CN, Finegold M et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 1996; 12: 266-273
32. Meshinchi S, Woods WG, Stirewalt DL, Sweetser DA, Buckley JD, Tjoa TK et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 2001; 97: 89-94
33. Fritz J, Vogel W, Bares R, Horger M. Radiologic spectrum of extramedullary relapse of myelogenous leukemia in adults. AJR Am J Roentgenol 2007; 189: 209-218
34. Navarro M, Crespo C, Perez L, Martinez C, Galant J, Gonzalez I. Massive intrahepatic extramedullary hematopoiesis in myelofibrosis. Abdom Imaging 2000; 25: 184-186
35. Sozer S, Fiel MI, Schiano T, Xu M, Mascarenhas J, Hoffman R. The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome. Blood 2009; 113: 5246-5249
36. Mathews E, Laurie T, O'Riordan K, Nabhan C. Liver involvement with acute myeloid leukemia. Case Rep Gastroenterol 2008; 2: 121-124
37. Eisen A, Dovrish Z, Hadari R, Lew S, Amital H. Jaundice and acute liver failure as the first manifestation of acute myeloid leukemia. Isr Med Assoc J 2008; 10: 733-735
38. Barcos M, Lane W, Gomez GA, Han T, Freeman A, Preisler H et al. An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer 1987; 60: 827-837
39. Larrivee B, Niessen K, Pollet I, Corbel SY, Long M, Rossi FM et al. Minimal contribution of marrow-derived endothelial precursors to tumor vasculature. J Immunol 2005; 175: 2890-2899
40. Jiang S, Walker L, Afentoulis M, Anderson DA, Jauron-Mills L, Corless CL et al. Transplanted human bone marrow contributes to vascular endothelium. Proc Natl Acad Sci USA 2004; 101: 16891-16896
41. Kukk E, Wartiovaara U, Gunji Y, Kaukonen J, Buhring HJ, Rappold I et al. Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells. Br J Haematol 1997; 98: 195-203
42. Watarai M, Miwa H, Shikami M, Sugamura K, Wakabayashi M, Satoh A et al. Expression of endothelial cell-associated molecules in AML cells. Leukemia 2002; 16: 112-119
43. Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM et al. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 2011; 31: 2283-2290
44. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/ progenitor cell principals. Blood 2007; 109: 1801-1809
45. Sarry JE, Murphy K, Perry R, Sanchez PV, Secreto A, Keefer C et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rgammac-deficient mice. J Clin Invest 2011; 121: 384-395
46. Park C, Ma YD, Choi K. Evidence for the hemangioblast. Exp Hematol 2005; 33: 965-970
47. Colmone A, Sipkins DA. Beyond angiogenesis: the role of endothelium in the bone marrow vascular niche. Transl Res 2008; 151: 1-9
48. Doan PL, Chute JP. The vascular niche: home for normal and malignant hematopoietic stem cells. Leukemia 2012; 26: 54-62
49. Cho-Vega JH, Medeiros LJ, Prieto VG, Vega F. Leukemia cutis. Am J Clin Pathol 2008; 129: 130-142
50. Pezeshkian B, Donnelly C, Tamburo K, Geddes T, Madlambayan GJ. Leukemia mediated endothelial cell activation modulates leukemia cell susceptibility to chemotherapy through a positive feedback loop mechanism. PLoS One 2013; 8: e60823
51. Madlambayan GJ, Meacham AM, Hosaka K, Mir S, Jorgensen M, Scott EW et al. Leukemia regression by vascular disruption and antiangiogenic therapy. Blood 2010; 116: 1539-1547
52. Tyner JW, Yang WF, Bankhead A, Fan G, Fletcher LB, Bryant J et al. Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening. Cancer Res 2013; 73: 285-296.